Development of high-affinity monoclonal antibody using CD44 overexpressed cells as a candidate for targeted immunotherapy and diagnosis of acute myeloid leukemia-Reference-Cited by-同舟云学术

Development of high-affinity monoclonal antibody using CD44 overexpressed cells as a candidate for targeted immunotherapy and diagnosis of acute myeloid leukemia

Published:2018-02-18 Issue:1 Volume:26 Page:7-15
ISSN:1093-2607
Container-title:Human Antibodies
language:
Short-container-title:HAB

Author:

Amanzadeh Amir¹,Heidarnejad Fatemeh¹,Abdollahpour-Alitappeh Meghdad²,Molla-Kazemiha Vahid¹,Yari Shamsi³,Hadizadeh-Tasbiti Alireza³,Habibi-Anbouhi Mahdi¹,Abolhassani Mohsen²,Shokrgozar Mohammad Ali¹

Affiliation:

1. National Cell Bank of Iran, Pasteur Institute of Iran, Tehran, Iran

2. Immunology Department, Hybridoma Laboratory, Pasteur Institute of Iran, Tehran, Iran

3. Department of Mycobacteriology, Pasteur Institute of Iran, Tehran, Iran

Publisher

IOS Press

Subject

General Medicine,Immunology,Immunology and Allergy

Reference33 articles.

1. CD44 cell adhesion molecules;S.;Mol Pathol,1999

2. CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification;P.;Breast Cancer Res Trt,2010

3. I. Morath, T. Hartmann and V. Orian-Rousseau, CD44: More than a mere stem cell marker, The Int J Biochem Cell Biol, 2016.

4. The normal structure and function of CD44 and its role in neoplasia;R.;Mol Pathol,1998

5. Development trends for monoclonal antibody cancer therapeutics;J.M.;Nat Rev Drug Discov,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aberrant stem cell and developmental programs in pediatric leukemia;Frontiers in Cell and Developmental Biology;2024-03-27

2. Hyaluronan in the Extracellular Matrix of Hematological and Solid Tumors. Its Biological Effects;The Extracellular Matrix and the Tumor Microenvironment;2022

3. Obtaining and characterization of anti-testis monoclonal antibodies: Invaluable tools toward the identification of testis antigens involved in fertilization;Human Antibodies;2018-08-20

4. A developed antibody–drug conjugate rituximab-vcMMAE shows a potent cytotoxic activity against CD20-positive cell line;Artificial Cells, Nanomedicine, and Biotechnology;2018-03-09